Work Here?
Overview
Kandu combines non-invasive brain-computer interface therapy with AI-powered telehealth to support stroke recovery at home. It integrates the FDA-cleared IpsiHand BCI with remote clinical support, enabling at-home rehabilitation guided by clinicians. The merger of Kandu Health and Neurolutions creates a continuum of care from hospital discharge to long-term recovery, linking hardware-enabled therapy with ongoing remote care. The goal is to scale a combined BCI-assisted therapy and telehealth program to set a standard for at-home stroke rehabilitation.
About Kandu
Industries
Hardware
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
1963
Get referred to Kandu
See people who can refer or advise you
Simplify's Take
What believers are saying
- August 2026 publication strengthened IpsiHand credibility with peer-reviewed randomized evidence.
- The April 2025 merger and $30 million financing funded commercialization and market expansion.
- Kandu's updated September 2026 site signals active product, clinical, and company momentum.
What critics are saying
- Kandu depends on one stroke niche and one flagship device, IpsiHand.
- Reimbursement expansion still stops at Medicare Part B and selective private plans.
- If the 2026 trial momentum fades, competitors can copy the service wrapper quickly.
What makes Kandu unique
- Kandu pairs FDA-cleared IpsiHand BCI with telehealth stroke navigation at home.
- IpsiHand's 2026 randomized trial showed clinically meaningful gains over standard home exercise.
- CMS reimbursement code plus Medicare Part B access make Kandu unusually commercialized.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Unlimited Paid Time Off
Paid Holidays
Remote Work Options
Stock Options
401(k) Retirement Plan
Home Office Stipend
Company News
Kandu Health and Neurolutions have merged to form Kandu, Inc., aiming to revolutionize stroke recovery with a $30 million financing round co-led by Ally Bridge Group and AMED Ventures. The merger combines Neurolutions' BCI technology with Kandu Health's telehealth services to offer comprehensive stroke care. Kandu, Inc. seeks to improve post-stroke outcomes, reduce hospital readmissions, and enhance patient quality of life through integrated, patient-centered solutions.
Kandu Health and Neurolutions have merged to form Kandu, Inc., aiming to revolutionize stroke recovery by combining BCI technology with telehealth services. The merger, supported by a $30 million funding round led by Ally Bridge Group and AMED Ventures, positions Kandu as a leader in stroke care. Leo Petrossian becomes CEO, while Kirsten Carroll becomes CMO. The new company will offer integrated care, leveraging AI and data to enhance outcomes for stroke survivors.
There are no jobs for Kandu right now.
Find jobs on Simplify and start your career today
About Kandu
Industries
Hardware
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
New York City, New York
Founded
1963
There are no jobs for Kandu right now.
Find jobs on Simplify and start your career today